RA Capital Management, LLC, 10% Owner at BIOSPECIFICS TECHNOLOGIES CORP (BSTC), bought 5,390 shares at $21.50 ($117K) on 2008-12-31, disclosed to the SEC on 2009-01-07.
Open-market purchase of $117k BSTC by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.40 | 2,250 | $48K | 41.3% |
| 2 | $21.50 | 1,240 | $27K | 22.9% |
| 3 | $22.00 | 1,900 | $42K | 35.8% |
| Total | $21.63 avg | 5,390 | $117K | 100% |
| Filing → |
| KALA | BUY | 2018-10-05 | $40.0M | — | Filing → |
| ARVN | BUY | 2018-10-03 | $16.0M | — | Filing → |
| WVE | BUY | 2017-11-15 | $9.9M | — | Filing → |